The Mediterranean diet has long been associated with low cardiovascular disease risk in adult population.
The prevalence of the metabolic syndrome (MS) is increasing rapidly throughout the world, in parallel with the increasing prevalence of diabetes and obesity; thus, it is now considered as a major public health problem (1) . With the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) definition, prevalence of the MS in Europe, Asia, Australia, and North and South America ranges between 9.6% and 55.7%; with the World Health Organization (WHO) definition, prevalence ranges between 13.4% and 70.0%; and with the International Diabetes Federation definition, prevalence ranges between 7.4% and 50% (2) (3) (4) .
Regardless of the true actual figures, there is undoubtedly a dramatic increase of this condition, and therefore, emerging action should be taken to prevent and control its development. Lifestyle interventions, including dietary changes and physical activity, play a crucial role in the prevention of this condition (5) . In fact, the NCEP ATP III has already suggested dietary intervention to prevent this epidemic. Diets rich in whole grain cereals, fruits, and vegetables, with low animal-fat consumption, seem to confer the prevention of cardiovascular disease risk factors, like hypertension, hypercholesterolemia, and obesity (6) . The Mediterranean diet (MD) is a dietary pattern that has already shown its cardioprotective effects. The MD was first presented by Ancel Keys in the 1960s (7), and it is characterized by high consumption of monounsaturated fatty acids, primarily from olives and olive oil, and encourages daily consumption of fruits, vegetables, whole grain cereals, and low-fat dairy products; weekly consumption of fish, poultry, tree nuts, and legumes; a relatively low consumption of red meat, approximately twice/month; as well as a moderate daily consumption of alcohol, normally with meals. The beneficial role of the MD with regard to mortality from all causes, cardiovascular disease (CVD) and cancer (8) , as well as obesity and type 2 diabetes (9,10) has already been reported from the results of many epidemiological studies and clinical trials. Major biopathophysiological mechanisms include antioxidant and anti-inflammatory effects of the foods included in the Mediterranean dietary pattern (9, (11) (12) (13) (14) (15) (16) (17) . However, the influence of the MD on the development of the MS has never been extensively studied. Thus, the aim of this work was to perform a systematic review and a meta-analysis of the findings of published original research articles in which the investigators have assessed the effect of a Mediterranean type of diet on the development of the MS as well as on its components.
Methods

Data sources.
Original research studies that were published in English until April 30, 2010 were selected through a computer-assisted published data search (i.e., PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials databases). Computer searches used combinations of Medical Subject Headings or other key words relating to the aim of the study (i.e., MD, moderate fat diet, monounsaturated fat diet, MS, syndrome X). Also, specific searches were included: MD and high-density lipoprotein (HDL)-cholesterol, MD and triglycerides, MD and blood pressure, MD and glucose, MD and waist circumference. In addition, the reference list of the retrieved articles was in some cases used to find other articles relevant to the present articles that were not allocated through the searching procedure. The initial search resulted in 48 entries in PubMed on MD and MS, 31 entries on MD and syndrome X, 94 entries on MD and HDL cholesterol, 77 entries on MD and triglycerides, 106 entries on MD and blood pressure, 26 entries on MD and waist circumference, and 92 entries on MD and glucose. The relevance of studies was assessed with a hierarchical approach on the basis of title, abstract, and the full manuscript. For the reports that were not fully available, a copy of the article was requested from the authors.
Study selection.
In total, 474 studies that evaluated the effect of an MD on MS and its components were identified. Exclusion criteria with regard to clinical trials included studies that reported lack of randomization, lack of a control diet group, comparison of the MD against the MD plus an additional intervention or intervention without inclusion of all the components of an MD and especially olive oil. Observational studies and clinical trials not published in English and studies that performed a post hoc analysis of previously published studies-already selected for this review-were also excluded. Thus, of the initial 474 studies that were extracted from the search machines, 398 were excluded on the basis of the title or abstract (i.e., irrelevant research hypothesis studied). Of the remaining 76 studies, 24 were excluded for the following reasons: lacking a control group (n ϭ 7), intervention of Mediterranean versus a Mediterranean plus diet (n ϭ 5), not clear MD (n ϭ 6), written in a language other than English (n ϭ 5), and post-hoc analysis (n ϭ 1). Therefore, 52 studies were eligible for inclusion in the meta-analysis. Studies included in the meta-analysis were those that had available results in a form that could be used for the present analysis. When it was necessary, data in the required form were requested from the authors. Overall, 50 studies with a total of 534,906 participants were finally included in this meta-analysis; of these, 2 were prospective, 13 were cross-sectional, and 35 were clinical trials. In addition, for the meta-analysis of the selected studies, the MOOSE (Meta-analysis Of Observational Studies in Epidemiology) and QUOROM (Quality of Reporting of Meta-analyses) guidelines have been followed (18, 19) (Fig. 1) . Data extraction. The following characteristics were extracted from the original reports with a standardized data extraction form and included in the meta-analysis: design of the study (clinical-trial, cross-sectional, or prospective cohort), lead author, year of publication, country of origin, sample size, mean age and gender of participants, health status, follow-up duration, effect size measurements (i.e., relative risk, odds ratio), and variables that entered into the multivariable model as potential confounding factors.
Two investigators (C.M.K., D.B.P.) collected the relevant reports, whereas 2 other authors independently reviewed the published data (H.M., J.G.), and disagreements were solved by consensus and by the opinion of a fifth author, if necessary. Outcomes of interest were development or progression of the MS and changes in the levels of the main components of the MS: waist circumference (in cm), HDL cholesterol (in mg/dl), triglycerides (in mg/dl), systolic and diastolic blood pressure (in mm Hg), as well as glucose (in mg/dl). When the data were provided in other units (i.e., mmol/l), they were transformed into mg/dl for consistency of the results. Quality of studies was assessed according to the number of participants, the duration of follow-up, and adjustment for potential confounders. Studies with a high number of participants (i.e., Ͼ30/ group for trials or Ͼ1,000 for observational), long dura- tion of follow-up (Ͼ3 months for trials or Ͼ1 year for observational), and adjustment for confounding factors (including demographic, anthropometric, and traditional risk factors) were considered to be of high quality. The characteristics of the studies and the diet regimens are shown in Tables 1 and 2 . Statistical analysis. Random effects meta-analysis of the selected studies was applied on the basis of within-study comparisons, thereby avoiding any biases being caused by methodological differences between studies. Each study was represented by a dummy variable, and the use of a randomeffects model was possible, because standard errors of the point estimates within studies were provided by the investigators. With regard to the analysis for the MS, each data point consisted of adherence to the MD and the odds ratio or the relative risk (hazard ratio) of having the MS. The estimated models used as dependent variables the (eventual) presence or absence of MS. With regard to the analysis for the components of the syndrome, each data point consisted of adherence to the MD and the difference in mean values and SD, of the group closer to the MD and the group away from the diet for epidemiological studies, while for clinical trials of the difference in mean values and SD after the intervention and at baseline, in the intervention and the control group. The validity of the models was examined with the influence of each separate data point (i.e., study) on the estimated regression coefficients. The latter was assessed with the use of Cook's distance to detect possible outliers. Heterogeneity was assessed with Cochran's Q and I 2 (I 2 ranges between 0% and 100%, with lower values representing less heterogeneity) and evaluated with the chisquare test. To examine the source of heterogeneity, sensitivity analyses were performed according to some characteristics of the studies, such as: country of origin (Mediterranean or not), follow-up time (below or above the median of the clinical trials [i.e., 3 months]), number of participants in clinical trials (below or above the median size [i.e., 66 participants]), recommendation regarding physical activity (yes or no), and quality of intervention (i.e., clinical trials with Ͼ30 participants and duration of follow-up Ͼ3 months or not). To assess the presence of publication bias, the "funnel plot" was tested. All statistical calculations were performed in NCSS 2004 software (Number Cruncher Statistical Systems, Kaysville, Utah).
Results
Sample sizes of the 15 observational studies that were included in the meta-analysis varied between 328 and 497,308 and, for the 35 clinical trials, varied between 8 and 1,224 participants; 35 of the selected studies were conducted in Mediterranean populations, 6 were performed in U.S. populations (20 -25) , 7 were performed in northern European populations (26 -32) , 1 was performed in a European population (Mediterranean and non-Mediterranean) (33), and 1 was performed in an Australian population (34) .
MD and MS.
Eight studies with 10,399 subjects evaluated the role of the MD on the development or progression of the MS. Five of these 8 studies (35) (36) (37) (38) (39) reported a beneficial effect of compliance with the MD, as compared with the control diet (i.e., low-fat diet or usual care) or with low adherence to the Mediterranean dietary pattern. Overall, adherence to the MD was associated with a beneficial effect with regard to the MS in 2 of 2 clinical trials, in 1 of 2 prospective studies, and in 2 of 4 cross-sectional studies, as compared with lower compliance with this pattern or with a control diet (i.e., low-fat diet or usual care) (Fig. 2) . The combined effect of both clinical trials and prospective studies was highly protective (log-hazard ratio ϭ Ϫ0.69, 95% CI: Ϫ1.24 to Ϫ1.16), whereas the combined effect of cross-sectional studies was not significant (log-odds ratio ϭ Ϫ0.16, 95% CI: Ϫ0.49 to 0.17). No publication bias was observed as indicated by the funnel plot (not presented here).
MD and MS components. WAIST CIRCUMFERENCE LEVELS.
Three cross-sectional studies (20, 33, 40) reported a beneficial effect of close adherence to the MD, as compared with low adherence (Table 3) . Heterogeneity of the effect measures regarding waist circumference was observed [Cochran's Q ϭ 628.32(4), p Ͻ 0.001, I 2 ϭ 99.4%]. Moreover, 11 clinical trials with 1,646 subjects (997 assigned to an MD, and 669 assigned to a control diet) evaluated the role of adherence to the MD on waist circumference. Overall, adherence to the MD was associated with a beneficial effect with regard to waist circumference as compared with the control diet (Table 4) ; but, it should be noted that the previous finding was mainly attributed to 1 study (21) that found a beneficial effect of the MD, as compared with the control diet. No significant heterogeneity of the effect measures regarding waist circumference [Cochran's Q ϭ 8.23 (13) , p ϭ 0.83, I
2 ϭ ϳ 0%] was observed.
LIPIDS LEVELS.
Three studies (14, 20, 40) reported a beneficial effect of close adherence to the MD on HDL cholesterol levels, as compared with low adherence. Overall, adherence to the MD was associated with higher HDL-cholesterol levels as compared with the control diet ( Table 3) . Heterogeneity of the effect measures was observed [Cochran's Q ϭ 52.78(6), p Ͻ 0.001, I 2 ϭ 88.6%]. Moreover, 29 clinical trials with 3,822 subjects (2,202 assigned to an MD, and 1,903 assigned to a control diet) examined the effect of adherence to the MD on HDL-cholesterol. Seven studies (31, 39, (41) (42) (43) (44) (45) reported a beneficial effect of an MD, as compared with the control diet, whereas 2 studies reported a beneficial effect of a high saturated fat diet as compared with the MD (46, 47) . Overall, adherence to the MD was associated with higher HDL-cholesterol levels as compared with the control diet ( Observational studies (n ϭ 16). apo ϭ apolipoprotein; BMI ϭ body mass index; CHD ϭ coronary heart disease; CVD ϭ cardiovascular disease; DM ϭ diabetes mellitus; IDF ϭ definition of the MS according to the International Diabetes Federation ( Clinical trials (n ϭ 36). chol ϭ cholesterol; CHO ϭ carbohydrates; IHD ϭ ischemic heart disease; LCM ϭ low-carbohydrate Mediterranean diet; MI ϭ myocardial infarction; MUFA ϭ monounsaturated fatty acids; Pro ϭ protein; PUFA ϭ polyunsaturated fatty acids; SF ϭ saturated fat; SFA ϭ saturated fatty acids; TM ϭ traditional Mediterranean diet; other abbreviations as in Table 1 . Data are presented as mean difference between highest versus lowest category of diet score (95% confidence interval). *Significant associations. BP ϭ blood pressure; HDL ϭ high-density lipoprotein; HOMA-IR ϭ Homeostatic Model Assessment insulin resistance; other abbreviations as in Table 1 .
Characteristics of Clinical Trials That Evaluated Effect of MD on Development of MS and/or Its Components
Results From Observational Studies That Evaluated the Effect of MD on Components of MS
MD was associated with lower triglycerides levels ( (2, 202 assigned to an MD, and 1,903 assigned to a control diet) examined the relationship between compliance with the Mediterranean dietary pattern and triglycerides levels. Five studies (39, 42, 43, 45, 49) reported a beneficial effect of an MD, as compared with the control diet, whereas the rest of the studies observed no significant differences. Overall, adherence to the MD was associated with lower triglyceride levels as compared with the control diet ( Table 4) . Heterogeneity of the effect measures regarding triglyceride levels [Cochran's Q ϭ 89.50 (40) , p Ͻ 0.001, I 2 ϭ 55.3%] was also evident.
BLOOD PRESSURE LEVELS.
Five observational studies with 15,535 participants were included in the analysis. Two studies (14, 40) reported a beneficial effect of close adherence to the MD on systolic blood pressure, as compared with low adherence, whereas 1 study showed higher systolic blood pressure levels for the group more closely following the MD (50) . Overall, adherence to the MD was not associated with systolic blood pressure levels, as compared with the control diet ( Table 3) . Heterogeneity of the effect measures regarding systolic blood pressure levels was also observed [Cochran's Q ϭ 161.28(5), p Ͻ 0.001, I 2 ϭ 96.8%]. Moreover, 14 clinical trials with 3,060 subjects (1,632 assigned to an MD, and 1,436 assigned to a control diet) evaluated the effect of the MD on systolic blood pressure levels. Three Figure 1 Process of Study Selection
Studies (n ϭ 474) that evaluated the effect of a Mediterranean diet on metabolic syndrome and its components were identified. After exclusions, 50 studies were finally included in the meta-analysis.
Figure 2 Mediterranean Diet and Metabolic Syndrome
Forest plot of studies that evaluated the effect of Mediterranean diet on the presence of the metabolic syndrome (squares and diamonds represent effect size; extended lines show 95% confidence intervals [CIs] ). Adherence to the Mediterranean diet was associated with a protective effect in 2 of 2 clinical trials, 2 of 4 crosssectional studies, and 1 of 2 prospective studies, as compared with lower compliance with this pattern or with a control diet. The combined effect of both clinical trials and prospective studies was highly protective (log-hazard ratio: Ϫ0.69, 95% CI: Ϫ1.24 to Ϫ1.16). *Log(odds ratio) or log(relative risk). studies (39, 42, 43) reported a beneficial effect of an MD, as compared with the control diet, and the overall adherence to the MD was associated with lower systolic blood pressure levels as compared with the control diet (Table 4) . Heterogeneity of the effect measures regarding systolic blood pressure levels was observed [Cochran's Q ϭ 31.18 (15) , p ϭ 0.01, I 2 ϭ 51.8%]. With regard to diastolic blood pressure levels, no significant associations were observed in observational studies (Table 3) . However, in clinical trials (3,060 subjects, 1,632 assigned to an MD, and 1,436 assigned to a control diet) 5 studies (39,41-43,51) reported a beneficial effect of an MD, and the overall effect suggested that adherence to the MD was associated with lower diastolic blood pressure levels as compared with the control diet ( Table 4) . No heterogeneity of the effect measures regarding blood pressure levels [Cochran's Q ϭ 16.09(15), p ϭ 0.38, I 2 ϭ 6.7%] was observed.
Results From Clinical Trials That Evaluated Effect of MD on Components of MS
GLUCOSE AND HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE LEVELS.
Two observational studies (40,52) reported a beneficial effect of close adherence to the MD as compared with the control diet, and overall adherence to the MD was associated with lower fasting glucose levels (Table 3) . Heterogeneity of the effect measures regarding glucose levels was observed [Cochran's Q ϭ 65.05 (7), p Ͻ 0.001, I 2 ϭ 89.2%]. Moreover, among the 17 clinical trials with 2,373 subjects (1,357 assigned to an MD, and 1,139 assigned to a control diet), 6 studies (39,41-43,45,53) reported a beneficial effect of an MD, as compared with the control diet. Overall, adherence to the MD was associated with lower fasting glucose levels as compared with the control diet ( Table 4) . Heterogeneity of the effect measures regarding glucose levels was observed [Cochran's Q ϭ 77.49 (22) , p Ͻ 0.001, I 2 ϭ 71.6%]. Two observational studies with 3,042 subjects evaluated the role of the MD on Homeostatic Model Assessment insulin resistance (HOMA-IR) levels (40, 52) . Both studies reported a beneficial effect of close adherence to the MD on HOMA-IR levels, as compared with low adherence (Table 3) . Heterogeneity of the effect measures regarding HOMA-IR levels [Cochran's Q ϭ 135.69(2), p Ͻ 0.001, I 2 ϭ 98.5%] was observed. In addition, 10 clinical trials with 1,742 subjects (1,031 assigned to a MD and 711 to a control diet), examined the relationship between adherence to the MD and HOMA-IR. Six studies (30, 39, 41, 42, 44, 51) reported a beneficial effect of a MD, as compared with the control diet. Overall, adherence to the MD was associated with lower HOMA-IR levels as compared with the control diet ( Table 4) Tables 2 and 3 .
revealed the beneficial role of the MD on MS, whereas results from observational studies (cross-sectional and prospective) showed a protective but not significant trend (Fig. 2) . Moreover, the heterogeneity found regarding the overall effect of diet on MS was not attributed to the weight of each study. However, heterogeneity was also observed with regard to the effect of diet on MS components. Specifically, differences were revealed with regard to: location of the studied population (i.e., Mediterranean or non-Mediterranean countries), sample size, duration of the intervention, encouraging of lifestyle changes, as well as trial quality. In particular, in studies conducted in Mediterranean countries, the effect of diet was significant with regard to all MS components except for weight circumference, whereas in studies not located in the Mediterranean region the effect of diet was not associated with any of the MS components; similarly, studies with intervention duration more than 3 months showed significant results for all the components studied except for waist circumference, whereas clinical trials with a Ͻ3-month intervention showed significant results only with regard to diastolic blood pressure and glucose levels. Moreover, all studies with sample size above the median (i.e., n Ͼ66) presented significant associations between diet and all the MS components, whereas studies with Ͻ66 participants did not show any significant associations. Studies also encouraging physical activity showed significant associations with regard to all the components studied, except waist circumference; however, studies focusing only on dietary intervention showed significant associations only with regard to blood pressure and glucose levels. Clinical trials of high quality showed significant results between diet and all the components studied, except for waist circumference, whereas clinical trials with low quality showed significant results only with regard to diastolic blood pressure and glucose levels (Table 5) . Furthermore, when the control diets were categorized (where this was possible) into "low-fat diet" (i.e., Ͻ30% fat),"usual treatment" type (i.e., no further dietary advice apart from that of hospital dietitians or written advice), "high saturated fat diet" (i.e., saturated fat Ͼ20%), the subgroup meta-analysis showed that MD was associated with beneficial effects, as compared with the "low-fat diet" (with regard to HDL cholesterol, triglycerides, systolic and diastolic blood pressure, glucose levels) as well as with the "usual dietary recommendations" (with regard to HDL cholesterol and triglyceride levels).
Discussion
The present meta-analysis, performed in 50 studies, with an overall incorporated population of approximately one-half million subjects, revealed the beneficial effect of the MD, with regard to not only the MS but also its individual components, namely waist circumference, HDL cholesterol levels, triglyceride levels, blood pressure levels, and glucose metabolism. The significant heterogeneity observed mainly Sensitivity Analysis of Selected Studies in Present Meta-Analysis Data are presented as mean difference between intervention groups (95% confidence interval). *Significant associations; †n ϭ number of studies.
Abbreviations as in Table 3 . on the effect of the MD on MS components was partially attributed to the location of studies (i.e., Mediterranean or not), the intervention duration, the number of the participants, and the quality of the studies. To the best of our knowledge, this is the first work that has systematically assessed, through meta-analysis, the role of the MD on MS and its components. The MD is one of the most known and well-studied dietary patterns, which has been shown to be associated with human health, especially decreased mortality from all causes, lower risk for cardiovascular disease, and cancer (8); it is also exerting a beneficial role with regard to type 2 diabetes and obesity (9, 10) . The results of the present meta-analysis add to the existing knowledge, because they indicate that adherence to the MD has a positive effect on human health through different ways. The MD has a beneficial effect on abdominal obesity, lipids levels, glucose metabolism, and blood pressure levels, all the components of the MS, which are also risk factors for the development of cardiovascular disease, insulin resistance, and diabetes. The antioxidant and anti-inflammatory effects of the MD as a whole as well as the effects of the individual components of the MD and specifically olive oil, fruits and vegetables, whole grains, and fish could offer a possible explanation for the aforementioned findings (9, (11) (12) (13) (14) (15) .
At this point it should be mentioned that abdominal obesity is one of the main causes for the appearance of all the components of the MS, because adipose tissue plays an important role in lipid and glucose metabolism and is responsible for the production of various cytokines influencing the development of the syndrome (54) . The present meta-analysis based on results from both observational studies and clinical trials revealed the beneficial effect of the MD with regard to central obesity.
Furthermore, results from studies conducted in Mediterranean countries showed more prominent effects of the Mediterranean-type dietary pattern, possibly due to the easy access of consumers to the Mediterranean products. Nevertheless, these results could be attributed to other potential confounders such as genetics or environmental factors (i.e., physical activity; food sources, enrichment, contamination). In addition results of the present meta-analysis suggested that adherence to the MD coupled with physical activity has even more beneficial effects, showing the significant role of an active lifestyle for the prevention of the MS components. Finally, studies of high quality, longer intervention duration, and higher number of participants showed more prominent results-a fact that can be attributed to the crucial role of the design of a study. Practical implications. The prevalence of the MS has drastically increased during recent years and is very unlikely to decrease, unless drastic measures are applied. For the delay and prevention of its development, emphasis should be placed on modifiable lifestyle factors. However, in spite of efforts to promote a healthy lifestyle and encourage a healthier diet and increase physical activity, dietary habits in the developed world and in some developing countries are changing toward the opposite direction. Even around the Mediterranean basin, consumption of fat, meat, eggs, dairy products, and sugar has increased, and consumption of cereals, legumes, vegetables, and seafood has decreased. Therefore, encouraging adherence to the MD might be a solution to the problem, because the foods comprising this dietary pattern-apart from its various health benefits-are tasty and it is easy to follow in the long-term. Study limitations. Certain limitations of this study warrant consideration. The Mediterranean dietary pattern is not homogeneous; however, the basic characteristics of this diet were present in all of the included epidemiological studies. In addition, the MD intervention varied between the clinical trials in terms of hours of intervention, detail of the recommendations given, and macronutrient composition of the diet. In most trials, the control diet was a low-fat, high-carbohydrate diet (21, 23, 24, 42, 43, 46, 47, 49, 53, (55) (56) (57) (58) (59) (60) (61) (62) , a low-carbohydrate diet (49, 63) , a prudent diet (30, 32) , usual patient treatment (22, 64) , American Diabetes Association diet (45) , receiving general healthy dietary information (27, 29, 31, 39, 41) , high-saturated-fat diet (30, 34, 46, 47, 53, (58) (59) (60) (61) , or less counselling on an MD prescription (51). In 9 trials, MD was part of a lifestyle intervention comprising exercise (24, 32, 43) or a structured plan (smoking cessation, exercise, stress management) (21, 22, 29, 39, 41, 45) . Moreover, significant heterogeneity is present in our analysis, which introduces a warning about the generalization of the present results. More cohort studies evaluating the role of the MD on MS are needed.
Conclusions
The results of the present meta-analysis suggest that adherence to the Mediterranean dietary pattern was associated with lower MS prevalence and progression. Moreover, greater adherence to this traditional dietary pattern was associated with favorable effects on the MS components. These results are of considerable public health importance, because this dietary pattern can be easily adopted by all population groups and various cultures (65) and costeffectively serve for the primary and secondary prevention of the MS and its individual components. 
